Ming Lu
Directeur Général chez Hangzhou Shangjian Biotechnology Co., Ltd.
Provenance du réseau au premier degré de Ming Lu
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Hangzhou Shangjian Biotechnology Co., Ltd.
 Hangzhou Shangjian Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Hangzhou Shangjian Biotechnology Co., Ltd. is a company that develops, manufactures, and markets therapeutic antibody drugs and antibodies. The company is based in Hangzhou, China. The Chinese company was founded in 2015 by Ming Lu, who has been the CEO since 2015.
9
| Holding Company | Pharmaceuticals: Major | 9 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Ming Lu via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| HUMANWELL HEALTHCARE (GROUP) CO.,LTD. | Pharmaceuticals: Major | Director/Board Member | |
| BEIJING CHIEFTAIN CONTROL ENGINEERING TECHNOLOGY CO., LTD. | Industrial Machinery | Director/Board Member | |
| DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. | Miscellaneous Commercial Services | Director/Board Member | |
| Nankai University | College/University | Masters Business Admin | |
| SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Dizal Pharma
 Dizal Pharma BiotechnologyHealth Technology Dizal Pharma is a Chinese biotechnology company that operates in an undisclosed location. The company was founded in 2017, and its CEO is Xiao Lin Zhang. | Biotechnology | Director/Board Member | |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Tianjin University | College/University | Undergraduate Degree | |
ADDOR Capital Management Co. Ltd.
 ADDOR Capital Management Co. Ltd. Investment ManagersFinance ADDOR Capital Management Co. Ltd is founded in 2010 and headquartered in Nanjing, China. | Investment Managers | Private Equity Investor | |
China Immunotech (Beijing) Biotechnology Co., Ltd.
 China Immunotech (Beijing) Biotechnology Co., Ltd. BiotechnologyHealth Technology China Immunotech (Beijing) Biotechnology Co., Ltd. is a biotechnology company based in Beijing, China. The company's description is written in a mix of Chinese and English, making it difficult to understand. The company was founded in 2018 by Xue Qiang Zhao, Hong Li Zheng, Wei Rui, and Wei Rui has been the CEO since 2018. | Biotechnology | Director/Board Member |
Statistiques
Internationale
| Chine | 11 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
| Producer Manufacturing | 2 |
| Commercial Services | 2 |
| Finance | 2 |
Opérationnelle
| Director/Board Member | 15 |
| Independent Dir/Board Member | 5 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
| Private Equity Investor | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Xue Gong Wang | 9 |
| Zheng Hua Ren | 2 |
| Yan Jiao Yan | 2 |
| Shi Wei Miao | 1 |
| Bin Tan | 1 |
| Ming Jin | 1 |
| Yun Tao Zhang | 1 |
| Rui Huang | 1 |
| Yan Hua Lu | 1 |
